nach oben

International Journal of Mental Health and Addiction

Erschienen in:

01.07.2007

The Rise of a New Psychoactive Agent: Salvia divinorum

verfasst von: Jonathan Appel, Dohee Kim-Appel

Erschienen in: International Journal of Mental Health and Addiction | Ausgabe 3/2007

Einloggen, um Zugang zu erhalten

Abstract

Since the 1990s, there has been a rise in the availability and recreational use of a herbal plant called Salvia divinorum. Numerous internet websites have advertised it for sale as a legal herbal alternative to illegal hallucinogens. Initial data surveying use has indicated many young adults are obtaining and using this herb for its psychoactive properties. Reported methods of ingestion for the plant include chewing, and smoking leaves or fortified extracts. Subjective effects of the plant include, affect changes, psychedelic-like changes in perception, and even loss of consciousness. Although the pharmacological properties and possible antidepressant effects have been studied in recent years, little information is known about potential negative impact resulting from recreational use, and scant information about Salvia divinorum currently exists in the psychological and substance abuse literature. While Salvia divinorum appears to be a substance with some therapeutic potential, it also poses some significant dangers as a substance of varying legal status with a potential for abuse.

Baggott, M. J., Erowid, E., Erowid, F., & Mendelson, J. E. (2004). Use of salvia divinorum, an unscheduled hallucinogenic plant: A web-based survey of 500 users. Clinical Pharmacology and Therapeutics 75, 72.

Chavkin, C., Sud, S., Jin, W., Stewart, J., Zjawiony, J. K., Siebert, D. J., et al. (2004). Salvinorin A, an active component of the hallucinogenic sage Salvia divinorum, is a highly efficacious kappa opioid receptor agonist: Structural and functional considerations. The Journal of Pharmacology and Experimental Therapeutics, 308(3), 1197–1203.PubMedCrossRef

Devine, D. P., Leone, P., Pocock, D., & Wise, R. A. (1993). Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. The Journal of Pharmacology and Experimental Therapeutics, 266, 1236–1246.PubMed

Di Chiara, G., & Imperato, A. (1988). Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. The Proceedings of the National Academy of Sciences of the USA, 85, 5274–5278.CrossRef

Donzanti, B. A., Althaus, J. S., Payson, M. M., & Von Voigtlander, P. F. (1992). Kappa agonist-induced reduction in dopamine release: Site of action and tolerance. Research Communications in Chemical Pathology and Pharmacology, 78, 193–210.PubMed

Drug Enforcement Administration. (2007). List of drugs and chemicals of concern. Internet website: http://www.deadiversion.usdoj.gov/drugs_concern/salvia_d/salvia_d.htm.

Epling, C., & Játiva-M, C. D. (1962). A new species of salvia from Mexico. Botanical Museum. Leaflets Harvard University, 20, 75–76.

Glick, S. D., Maisonneuve, I. M., Raucci, J., & Archer S. (1995). Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Research, 681, 147–152.PubMedCrossRef

González, D., Riba, J., Bouso, J. C., Gómez-Jarabo, G., & Barbanoj, M. J. (2006). Pattern of use and subjective effects of salvia divinorum among recreational users. Drug and Alcohol Dependence, 85(2), 157–162.PubMedCrossRef

Haynes, K. R. (2001). Antidepressant effects of the herb salvia divinorum: A case report. Journal of Clinical Psychopharmacology, 21(6), 634–635.CrossRef

Kuzmin, A. V., Semenova, S., Gerrits, M., Zvartau, E. E., & Van Ree, J. M. (1997). K-Opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naïve rats and mice. European Journal of Pharmacology, 321, 265–271.PubMedCrossRef

Prisinzano, T. E. (2005). Psychopharmacology of the hallucinogenic sage salvia divinorum. Life Sciences, 78(5), 527–531.PubMed

Rey, J, & Tennant, C. (2002). Cannabis and mental health. British Medical Journal, 325, 1183–1184.PubMedCrossRef

Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., & Rothman R. B. (2002). Salvinorin A: A potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proceedings of the National Academy of Sciences of the USA, 99(18), 11934–11939.PubMedCrossRef

Schaper D. (2006). National Public Radio: Legal, herbal hallucinogenic draws teens, critics. Radio broadcast Washington, DC: NPR.

Schenk, S., Partridge, B., & Shippenberg, T. S. (1999). U69593, a kappaopioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology, 144, 339–346.PubMedCrossRef

Sheffler, D. J., & Roth, B. L. (2003). Salvinorin A: The ‘magic mint’ hallucinogen finds a molecular target in the kappa opioid receptor. Trends in Pharmacological Sciences, 24(3), 107–109.PubMedCrossRef

Siebert, D. (1994). Salvia divinorum and salvinorin A: New pharmacologic findings. Journal of Ethnopharmacology, 43, 53–56.PubMedCrossRef

Spanagel, R., Herz, A., & Shippenberg, T. S. (1992). Opposing tonically active endogeneous opioid systems modulate the mesolimbic dopaminergic pathway. Proceedings of the National Academy of Sciences of the USA, 89, 2046–2050.PubMedCrossRef

Ukai, M., Suzuki, M., & Mamiya, T. (2002). Effects of U-50, 488H, a kappa opioid receptor agonist, on the learned helplessness model of depression in mice. Journal of Neural Transmission, 109, 1221–1225.PubMedCrossRef

Valdés, L. J. III (1994). Salvia divinorum and the unique diterpene hallucinogen, salvinorin (divinorin) A. Journal of Psychoactive Drugs, 26, 277–283.PubMed

Valdes, L. J. III, Diaz, J., & Paul, A. G. (1983). Ethnopharmacology of ska maria pastora (Salvia divinorum, Epling and Játiva-M.). Journal of Ethnopharmacology, 7, 287–312.PubMedCrossRef

Valdes, L. J. III, Butler, W. B., Hatfield, G. M., Paul, A. G., & Koreeda M. (1984). Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint, salvia divinorum. Journal of Organic Chemistry, 49, 4716–4720.CrossRef

Walsh, S. K., Geter-Douglas, B., Strain, E. C., Bigelow, G. E. (2001). Enadoline and butorphanol: Evaluation of k-agonist on cocaine pharmacodynamics and cocaine self-administration in humans. Pharmacology, 299, 147–158.

Wasson, R. G. (1962). A new Mexican psychotropic drug from the mint family. Botanical Museum Leaflets Harvard University, 20, 77–84.

Wasson, R. G. (1963). Notes on the present status of ololiuhqui and the other hallucinogens of Mexico. Botanical Museum Leaflets Harvard University, 20, 161–193.

Zhang, Y., Butelman, E. R., Schlussman, S. D., Ho, A., & Kreek, M. J. (2005). Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: Agonist actions at kappa opioid receptors. Psychopharmacology, 179, 551–558.PubMedCrossRef

Zhang, Y., Butelman, E. R., Schlussman, S. D., Ho, A., & Kreek, M. J. (2004). Effect of the k- opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice. Psychopharmacology, 173, 146–152.PubMedCrossRef

Titel: The Rise of a New Psychoactive Agent: Salvia divinorum
verfasst von: Jonathan Appel
Dohee Kim-Appel
Publikationsdatum: 01.07.2007
Verlag: Springer-Verlag
Erschienen in: International Journal of Mental Health and Addiction / Ausgabe 3/2007
Print ISSN: 1557-1874
Elektronische ISSN: 1557-1882
DOI: https://doi.org/10.1007/s11469-007-9086-4

Neu im Fachgebiet Psychiatrie

23.04.2024 | Demenz | Nachrichten

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

The Rise of a New Psychoactive Agent: Salvia divinorum

Abstract

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2007

Individual Factors and the Context of Physical Activity in Exercise Dependence: A Prospective Study of ‘Ultra-Marathoners’

Co-occurring Disorders, Emotion/Mood Literacy, and Emotion/Mood Regulation

Exercise and Internet Addiction: Communalities and Differences Between Two Problematic Behaviours

Management of Opioid Dependence in Pregnancy: A Review of the Evidence

Varenicline: A Novel Drug for Smoking Cessation

Editorial

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Psychiatrie